# Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-ca-22-026-limited-competition-a-data-resource-for-blood-and/  
Official notice: https://www.grants.gov/search-results-detail/341116

> National Institutes of Health offered grants of up to $5.5 million to small businesses. Applications closed on September 15, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-CA-22-026 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | September 15, 2022 |
| Award ceiling | $5.5 million |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.395, 93.839, 93.855 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. Please see Full Announcement for additional details on eligibility

## What the grant funds

The purpose of this limited competition Funding Opportunity Announcement (FOA) is to continue support for the Center for International Blood and Marrow Transplant Research (CIBMTR) as a data resource enabling broad studies on Hematopoietic Stem Cell transplantation (HCT) and Adoptive Cellular Therapy (ACT) research. The CIBMTR represents a network comprised of more than 380 US and international transplant centers that submit outcome data for patients receiving cellular therapies. The CIBMTR Statistical Center provides data acquisition and management and information technology services to maintain a unique contemporary clinical outcomes' database and facilitates observational and interventional research through scientific and statistical expertise necessary to support analyses of these data. NIH is supporting the CIBMTR to ensure the database remains available to the public and to improve the treatment, survival, and quality of life for patients diagnosed with cancer and non-malignant blood disorders.

## Questions people ask

### Is RFA-CA-22-026 still open?

No. It closed on September 15, 2022.

### Who can apply for Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)?

Closed September 15, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $5.5 million each.

### Who has been funded under RFA-CA-22-026?

NIH RePORTER lists 1 project funded under RFA-CA-22-026 in fiscal 2023 to 2026, at 1 institution.

### Who has won Cancer Treatment Research grants before?

The largest recipients over five fiscal years were The Univeristy of Texas M.D. Anderson Cancer Center, Dana-Farber Cancer Institute, Inc., Icahn School of Medicine at Mount Sinai. The program made 3,622 awards worth $5.6 billion in that time.